Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Autonomix MedicalAMIX -12.48%15 Cash Ratio is 4.11 as of Mar. 2026, which is 13% below its 10-year median of 4.73. GuruFocus rates AMIX with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 844 Medical Devices & Instruments companies, Autonomix Medical ranks better than 83.18% on this metric.
Autonomix Medical has a Cash Ratio of 4.11. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Autonomix Medical's Cash Ratio or its related term are showing as below:
AMIX'
s Cash Ratio Range Over the Past 10 Years
Min: 3.91 Med: 4.73 Max: 11.08
Current: 4.11
During the past 4 years, Autonomix Medical's highest Cash Ratio was 11.08. The lowest was 3.91. And the median was 4.73.
AMIX's Cash Ratio is ranked better than 83.18% of 844
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs AMIX: 4.11
Autonomix Medical (NAS:AMIX) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Autonomix Medical Cash Ratio Related Terms
Autonomix Medical Cash Ratio Historical Data
* Premium members only.
The historical data trend for Autonomix Medical's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Autonomix Medical's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Autonomix Medical Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Autonomix Medical's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Autonomix Medical (AMIX) has a Cash Ratio of 4.11 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Autonomix Medical and its competitors. This is 13% below median its historical median of 4.73. Over the past decade, Autonomix Medical's Cash Ratio has ranged from 3.91 to 11.08. According to the industry distribution chart, Autonomix Medical ranks #142 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 16.8%.
Is Autonomix Medical's Cash Ratio too high?
Autonomix Medical's current Cash Ratio of 4.11 is 13% below median its 10-year median of 4.73. Over the past 10 years, this metric has ranged from a low of 3.91 to a high of 11.08. The Medical Devices & Instruments industry median Cash Ratio is 0.97. Autonomix Medical's value of 4.11 is 323.7% above this industry median. Based on the distribution chart, Autonomix Medical ranks #142 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Autonomix Medical has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Autonomix Medical's Cash Ratio compare to BJDX and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Autonomix Medical ranks #142 out of 844 companies for Cash Ratio. This places Autonomix Medical in the top 17% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.97. Autonomix Medical's value of 4.11 is 323.7% above this benchmark. Historically, Autonomix Medical's own Cash Ratio has ranged from 3.91 to 11.08 over the past decade. While the company's 10-year median is 4.73 vs. the industry median of 0.97, Autonomix Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 844 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Autonomix Medical's current Cash Ratio of 4.11 is 323.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Autonomix Medical and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Autonomix Medical's current Cash Ratio is 4.11, which is 13% below median its own 10-year median of 4.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autonomix Medical stock overvalued right now?
Autonomix Medical (AMIX) has a current Cash Ratio of 4.11. The current Cash Ratio is 4.11, which is 13% below median its 10-year median of 4.73 and 323.7% above the Medical Devices & Instruments industry median of 0.97. Autonomix Medical's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Autonomix Medical (AMIX), the current Cash Ratio is 4.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
15GF Score
Get the complete analysis for AMIX
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMIX has been successfully added to your 
